Harbeck N - Search Results

1

Update Breast Cancer 2022 Part 3 - Early-Stage Breast Cancer.

Fehm TN, Welslau M, Müller V, Lüftner D, Schütz F, Fasching PA, Janni W, Thomssen C, Witzel I, Belleville E, Untch M, Thill M, Tesch H, Ditsch N, Lux MP, Aktas B, Banys-Paluchowski M, Schneeweiss A, Kolberg-Liedtke C, Hartkopf AD, Wöckel A, Kolberg HC, Harbeck N, Stickeler E. Fehm TN, et al. Among authors: harbeck n. Geburtshilfe Frauenheilkd. 2022 Sep 13;82(9):912-921. doi: 10.1055/a-1912-7105. eCollection 2022 Sep. Geburtshilfe Frauenheilkd. 2022. PMID: 36110894 Free PMC article.

2

[Possibilities in immunocytochemistry exemplified by bone marrow aspiration cytology in patients with breast carcinoma].

Eiermann W, Harbeck N, Untch M. Eiermann W, et al. Among authors: harbeck n. Gynakologe. 1990 Dec;23(6):358-64. Gynakologe. 1990. PMID: 2177719 German. No abstract available.

3

[Micrometastases in bone marrow at the time of primary treatment of breast cancer: a new prognostic criterion?].

Untch M, Harbeck N, Eiermann W. Untch M, et al. Among authors: harbeck n. Gynakol Rundsch. 1989;29 Suppl 2:231-3. Gynakol Rundsch. 1989. PMID: 2693244 German. No abstract available.

4

Micrometastases in bone marrow in patients with breast cancer.

Untch M, Harbeck N, Eiermann W. Untch M, et al. Among authors: harbeck n. Br Med J (Clin Res Ed). 1988 Jan 23;296(6617):290. doi: 10.1136/bmj.296.6617.290. Br Med J (Clin Res Ed). 1988. PMID: 3124916 Free PMC article. No abstract available.

5

Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.

Harbeck N, Untch M, Pache L, Eiermann W. Harbeck N, et al. Br J Cancer. 1994 Mar;69(3):566-71. doi: 10.1038/bjc.1994.103. Br J Cancer. 1994. PMID: 7510120 Free PMC article.

6

Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts.

Harbeck N, Schmitt M, Kates RE, Kiechle M, Zemzoum I, Jänicke F, Thomssen C. Harbeck N, et al. Clin Breast Cancer. 2002 Aug;3(3):196-200. doi: 10.3816/CBC.2002.n.023. Clin Breast Cancer. 2002. PMID: 12196277 Review.

7

Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.

Pantel K, Müller V, Auer M, Nusser N, Harbeck N, Braun S. Pantel K, et al. Among authors: harbeck n. Clin Cancer Res. 2003 Dec 15;9(17):6326-34. Clin Cancer Res. 2003. PMID: 14695131

8

Detection of micrometastatic disease in bone marrow: is it ready for prime time?

Janni W, Rack B, Lindemann K, Harbeck N. Janni W, et al. Among authors: harbeck n. Oncologist. 2005 Aug;10(7):480-92. doi: 10.1634/theoncologist.10-7-480. Oncologist. 2005. PMID: 16079315 Free article. Review.

9

Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials.

Loibl S, von Minckwitz G, Harbeck N, Janni W, Elling D, Kaufmann M, Eggemann H, Nekljudova V, Sommer H, Kiechle M, Kümmel S. Loibl S, et al. Among authors: harbeck n. Breast Cancer Res. 2008;10(5):R77. doi: 10.1186/bcr2144. Epub 2008 Sep 16. Breast Cancer Res. 2008. PMID: 18796139 Free PMC article.

10

Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.

Schwarz-Dose J, Untch M, Tiling R, Sassen S, Mahner S, Kahlert S, Harbeck N, Lebeau A, Brenner W, Schwaiger M, Jaenicke F, Avril N. Schwarz-Dose J, et al. Among authors: harbeck n. J Clin Oncol. 2009 Feb 1;27(4):535-41. doi: 10.1200/JCO.2008.17.2650. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

689 results

Search Page